SCP
BIIB icon

Shorepoint Capital Partners’s Biogen BIIB Stock Holding History

Shorepoint Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$626K Buy
2,236
+52
+2% +$14K 0.33% 65
2020
Q4 		$535K Buy
2,184
+43
+2% +$11.1K 0.3% 65
2020
Q3 		$607K Buy
2,141
+64
+3% +$17.9K 0.38% 62
2020
Q2 		$556K Sell
2,077
-724
-26% -$218K 0.36% 64
2020
Q1 		$886K Sell
2,801
-94
-3% -$28.5K 0.71% 50
2019
Q4 		$859K Sell
2,895
-122
-4% -$33.9K 0.49% 62
2019
Q3 		$702K Buy
3,017
+92
+3% +$21.4K 0.41% 64
2019
Q2 		$684K Buy
2,925
+1,033
+55% +$239K 0.39% 71
2019
Q1 		$447K Buy
+1,892
New +$596K 0.25% 75

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Shorepoint Capital Partners's BIIB Position: Q1 2021 in Review

Shorepoint Capital Partners increased its Biogen (BIIB) stake by 2.4% in Q1 2021, buying an estimated $14K and bringing the position to 2,236 shares worth $626K. The position accounts for 0.33% of the portfolio, ranked #65.

Shorepoint Capital Partners first reported a position in BIIB in Q1 2019 and has held it in 9 quarters since. The position peaked at $886K in Q1 2020. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Shorepoint Capital Partners held 2,236 shares of Biogen worth $626K as of Q1 2021.
  • Shorepoint Capital Partners bought 52 Biogen shares in Q1 2021, an estimated $14K.
  • Biogen made up 0.33% of Shorepoint Capital Partners's portfolio in Q1 2021, its #65 holding.
  • Shorepoint Capital Partners first reported a position in Biogen in Q1 2019 and has held it in 9 quarters since.
  • Shorepoint Capital Partners's Biogen position peaked at $886K in Q1 2020.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Shorepoint Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.